Integra Lifesciences Holdings (IART) Intangibles (2009 - 2026)

Integra Lifesciences Holdings (IART) has 18 years of Intangibles data on file, last reported at $1.1 billion in Q1 2026.

• For the quarter ending Q1 2026, Intangibles fell 6.92% year-over-year to $1.1 billion; the trailing twelve-month figure through Mar 2026 stood at $1.1 billion (down 6.92% YoY), and the FY2025 full-year result was $1.1 billion, down 6.04% from the prior year.
• Intangibles declined to $1.1 billion in Q1 2026, from $1.1 billion in the prior quarter.
• In the past five years, Intangibles ranged from a high of $1.2 billion in Q2 2024 to a low of $1.0 billion in Q1 2024.
• A 5-year average of $1.1 billion and a median of $1.1 billion in 2022 frame the typical range for Intangibles.
• Across the five-year window, Intangibles declined 8.8% in 2022 and climbed 16.13% in 2025, its largest moves.
• Tracing IART's Intangibles over 5 years: stood at $1.1 billion in 2022, then fell by 5.22% to $1.1 billion in 2023, then increased by 13.09% to $1.2 billion in 2024, then slipped by 6.04% to $1.1 billion in 2025, then retreated by 2.58% to $1.1 billion in 2026.
• Business Quant data shows IART's Intangibles at $1.1 billion in Q1 2026, $1.1 billion in Q4 2025, and $1.2 billion in Q3 2025.